These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 619141)

  • 1. Replacement of the disulfide bond in oxytocin by an amide group. Synthesis and some biological properties of (cyclo-(1-L-aspartic acid,6-L-alpha,beta-diaminopropionic acid))oxytocin.
    Smith CW; Walter R; Moore S; Makofske RC; Meienhofer J
    J Med Chem; 1978 Jan; 21(1):117-20. PubMed ID: 619141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and some pharmacological properties (4-beta-(2-thienyl)-L-alanine)oxytocin.
    Smith CW; Skala G; Walter R
    J Med Chem; 1978 Jan; 21(1):115-7. PubMed ID: 619140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active-site studies of neurohypophyseal hormones: synthesis and pharmacological properties of [5-(N4,N4-dimethylasparagine)]oxytocin.
    Walter R; Stahl GL; Caplaneris T; Cordopatis P; Theodoropoulos D
    J Med Chem; 1979 Jul; 22(7):890-3. PubMed ID: 448689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin and lysine-vasopressin with N5,N5-dialkylglutamine in the 4 position: effect of introducing sterically hindered groups into the hydrophilic cluster of neurohypophyseal hormones.
    Stahl GL; Smith CW; Walter R; Tsegenidis T; Stavropoulos G; Cordopatis P; Theodoropoulos D
    J Med Chem; 1980 Feb; 23(2):213-7. PubMed ID: 7359537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological effects of introducing a double bond into a binding site of oxytocin. Analogues with L-3,4-dehydroproline in position 7.
    Moore S; Felix AM; Meienhofer J; Smith CW; Walter R
    J Med Chem; 1977 Apr; 20(4):495-500. PubMed ID: 850234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of changing the COOH-terminal amide group present in the hydrophilic cluster of oxytocin to dimethylamide.
    Ting YF; Smith CW; Stahl GL; Walter R; Cordopatis P; Theodoropoulos D
    J Med Chem; 1980 Jun; 23(6):693-5. PubMed ID: 7392037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biofunctional evaluation of a hydrogen bond linking the ring and tail beta-turns of oxytocin.
    Roy J; Roy U; Gazis DC; Schwartz IL
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3309-13. PubMed ID: 291004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones.
    Walter R; Smith CW; Roy J; Formento A
    J Med Chem; 1976 Jun; 19(6):822-5. PubMed ID: 985884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic metabolites of neurohypophyseal hormones. (Des-9-glycinamide)oxytocin and (des-9-glycinamide, des-8-leucine)oxytocin.
    Walter R; Havran RT; Schwartz IL
    J Med Chem; 1976 Feb; 19(2):328-30. PubMed ID: 1249815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and some pharmacological properties of five analogs of oxytocin having L-homocysteine in position 6.
    Smith CW; Ferger MF
    J Med Chem; 1976 Feb; 19(2):250-4. PubMed ID: 1249804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological properties of [1-L-penicillamine,4-L-leucine]oxytocin.
    Ferger MF; Chan WY
    J Med Chem; 1975 Oct; 18(10):1020-2. PubMed ID: 1159679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and some pharmacological properties of [1-beta-mercapto-beta,beta-diethylpropionic acid,2-(3,5-dibromo-L-tyrosine)]oxytocin.
    Lundell EO; Smith CW; Ferger MF
    J Med Chem; 1975 Dec; 18(12):1262-4. PubMed ID: 1195281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (1-Beta-mercaptopropionic acid, 2-(3,5-dibromo-L-tyrosine))oxytocin, a potent inhibitor of oxytocin.
    Lundell EO; Ferger MF
    J Med Chem; 1975 Oct; 18(10):1045-7. PubMed ID: 1159688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and some pharmacological properties of 8-L-methionine-oxytocin.
    Bodanszky M; Chandramouli N; Martinez J; Walter R
    J Med Chem; 1979 Mar; 22(3):270-3. PubMed ID: 423209
    [No Abstract]   [Full Text] [Related]  

  • 15. [4-(0-methyl)-L-threonine] -oxytocin. Synthesis and uterotonic activity.
    Bańkowski K
    Pol J Pharmacol Pharm; 1988; 40(3):331-5. PubMed ID: 2853867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined high oxytocic with negligible antidiuretic and pressor activities in multisubstituted oxytocins.
    Stahl GL; Walter R
    J Med Chem; 1977 Apr; 20(4):492-5. PubMed ID: 850233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and some pharmacological properties of [8-L-tryptophan]oxytocin.
    Bodanszky M; Tolle JC; Seto J; Sawyer WH
    J Med Chem; 1980 Nov; 23(11):1259-61. PubMed ID: 7452679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-oxytocin).
    Manning M; Lowbridge J; Sawyer WH; Haldar J
    J Med Chem; 1976 Mar; 19(3):376-80. PubMed ID: 943546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (4-Phenylalanine)oxytocin, an inhibitor of the antidiuretic effect of 8-arginine-vasopressin.
    Nestor JJ; Ferger MF; Chan WY
    J Med Chem; 1975 Oct; 18(10):1022-4. PubMed ID: 1159680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonists of oxytocin featuring replacement with modified beta-mercaptopropionic acids at position 1.
    Flouret G; Majewski T; Balaspiri L; Brieher W; Mahan K; Chaloin O; Wilson L; Slaninová J
    J Pept Sci; 2002 Jul; 8(7):314-26. PubMed ID: 12148781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.